Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Augments Acute Lung Injury via Its Neutrophil Priming Effects by Choi, Jae Chol et al.
INTRODUCTION
Granulocyte macrophage-colony stimulating factor (GM-
CSF) is a glycoprotein of 22 kDa. It is synthesized and secreted
by a wide variety of activated cells including: T lymphocytes,
macrophages, lung epithelial cells, and cytokine-activated
endothelial cells (1, 2). GM-CSF plays an important role in
promoting the growth and differentiation of myelomono-
cytic progenitors (3, 4). The immuno-stimulatory effects of
GM-CSF have been widely applicated in clinical practice.
For example, febrile, neutropenic patients after chemothera-
py show significant increase in total white blood cell and
absolute neutrophil counts after GM-CSF treatment (5). On
the other hand, GM-CSF can enhance the functional respon-
siveness and extend the life of mature polymorphonuclear
leukocytes (6). Because neutrophils play a key role in systemic
inflammation, unnecessary prolongation of the life span of
granulocytes may augment tissue injury. As expected, admin-
istration of GM-CSF has been associated with side-effects such
as shock, hypoxia, liver dysfunction, and acute lung injury
(7, 8). In this sense, immuno-stimulatory effects of GM-CSF
can be beneficial or harmful depending on the clinical situation.
Acute lung injury (ALI) is a syndrome of severe dyspnea,
hypoxemia, and diffuse pulmonary infiltrates leading to res-
piratory failure. ALI is caused by many disorders that induce
either direct or indirect type of lung injury. Although sepsis
is one of the most common causes of ALI, blood loss is also
frequently associated with lung injury. For example, loss of
approximately 30% of total blood volume is an important
threshold predicting the subsequent development of ALI and
other organ system dysfunction (9). Although GM-CSF has
frequently been reported to participate in the development
of sepsis-induced lung injury, there has been no study eval-
uating the role of GM-CSF in hemorrhage-induced ALI.
In the present study, we hypothesized that GM-CSF plays an
important role not only in lipopolysaccharide (LPS)-induced
but also in hemorrhage-induced ALI. We also speculated
that GM-CSF augments LPS-induced inflammation by its
priming effect on neutrophils.
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Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Augments
Acute Lung Injury via Its Neutrophil Priming Effects
Granulocyte macrophage-colony stimulating factor (GM-CSF) has immuno-stimula-
tory effects. We hypothesized that GM-CSF plays an important role both in lipopoly-
saccharide (LPS)- and hemorrhage-induced acute lung injury (ALI). We also pos-
tulated that GM-CSF augments LPS-induced inflammation by priming neutrophils.
ALI was induced in GM-CSF-/- or control C57BL mice either by LPS injection or by
hemorrhage. Lung inflammation (by lung expression for tumor necrosis factor-
(TNF- ), macrophage inflammatory protein-2 (MIP-2), interleukin-1 (IL-1 ), inter-
leukin-6 (IL-6), and keratinocyte-derived chemokine) and lung injury (by myeloper-
oxidase and evans blue dye assay) were evaluated after ALI. Incremental doses
of LPS (0, 1, 10, and 100 ng/mL) and GM-CSF (0, 1, 10, and 100 ng/mL) were added
to bone marrow neutrophils. The expression of TNF- , MIP-2, and IL-1 was eval-
uated with enzyme linked immunosorbent assay. The mRNA expression of three
cytokines, and the nuclear translocation of nuclear factor kappa B (NF -B) were evalu-
ated by reverse transcriptase-polymerase chain reaction and electropnoretic mobil-
ity shift assay, respectively. GM-CSF -/- mice showed decreased neutrophil infiltra-
tion, less leakage, and lower expression of cytokines in the lung after LPS or hem-
orrhage. GM-CSF augmented LPS-induced protein and mRNA expression of TNF- ,
MIP-2 and IL-1 , which was mediated by increased intra-nuclear translocation of
NF- B. GM-CSF plays an important role in high-dose LPS and hemorrhage-induc-
ed ALI, which appears to be mediated by its priming effect on neutrophils. 
Key Words : Granulocyte-Macrophage Colony-Stimulating Factor; Adult, Respiratory Distress Syndrome;
Lipopolysaccharides; Hemorrhage; Neutrophils
Received : 10 May 2007
Accepted : 22 September 2007GM-CSF Augments Acute Lung Injury via Its Neutrophil Priming Effects 289
MATERIALS AND METHODS
Mice
Male Balb/c mice, 8-12 week of age, were purchased from
Harlan Sprague Dawley (Indianapolis, IN, U.S.A.). The mice
were kept on a 12:12-hr light-dark cycle with free access to
food and water. All experiments were conducted in accor-
dance with institutional review board-approved protocols.
GM-CSF knockout mice were kindly donated by Dr. Dra-
noff (Dana-Farber Cancer Institute, Boston, MA, U.S.A.), who
established and investigated mice carrying a null allele of
the GM-CSF gene (10). C57BL mice were purchased from
Jackson Laboratory (Bar Harbor, ME, U.S.A.) and used as
wild-type controls.
Model of endotoxemia
Both mice (GM-CSF -/- and control C57BL) received an
intraperitoneal injection of LPS at a dose of 0.5 mg/kg or 5
mg/kg in 0.2 mL phosphate buttered saline (PBS). Mice
were anesthesized 4 hr after LPS injection and chest was
opened and flushed by infusing 10 mL of PBS into beating
right ventricle. After then, lungs were removed and stored
at -70℃ before being used for cytokines and myeloperoxi-
dase (MPO) assay. 
Model for hemorrhage
The mouse hemorrhage model used in these experiments
has been described previously (11). In brief, mice were anes-
thesized with inhaled isofluorane. Cardiac puncture was used
to remove 30% of the calculated total blood volume (0.27
mL/10 g body wt) over 60 sec into a heparanized syringe.
One hour after the induction of hemorrhage, mice were again
anesthesized with isofluorane, and the previously removed
blood was infused into the retro-orbital venous plexus. The
sham procedure involved cardiac puncture under isofluorane
anesthesia, without blood removal, followed by a second epi-
sode of anesthesia and retro-orbital puncture 1 hr later.
Preparation of lung homogenate for enzyme linked
immunosorbent assay (ELISA)
Lung samples were homogenized in ice cold lysis buffer
(50 mM HEPES, 150 mM NaCl, 10% glycerol, 1% Triton
X-100, 1.5 mM MgCl2, 1 mM EGTA, 1 mM sodium vana-
date, 10 mM sodium pyrophosphate, 10 mM NaF, 300  M
p-nitrophenyl phosphate, 1 mM PMSF, 10  g/mL leupeptin,
10  g/mL aprotinin, pH 7.3) containing 1 mM of protease
inhibitor cocktail (Sigma, St Louis, MO, U.S.A.). Homogenates
were centrifuged at 14,000 g for 15 min and supernatant
was collected. The protein concentration of each sample was
assayed using the micro BCA protein assay kit standardized
to bovine serum albumin (BSA), according to manufactur-
er’s protocol (Pierce, Rockford, IL, U.S.A.). 
Myeloperoxidase assay
MPO activity was assayed as reported previously with
minor modifications (11). Lung tissue was homogenized in
1.0 mL of 50 mM potassium phosphate buffer (pH 6.0) con-
taining 10 mM N-ethylmaleimide for 30 sec on ice. The
homogenate was centrifuged at 12,000 g for 30 min at 4℃.
The proteinous pellet was homogenized once more in ice-
cold buffer, and the homogenate was centrifuged (12,000 g
for 30 min at 4℃). The pellet was resuspended and sonicat-
ed on ice for 90 sec in 10 times vol of hexadecyltrimethylam-
monium bromide buffer (0.5% hexadecyltrimethylammo-
nium in 50 mM potassium phosphate, pH 6.0). Samples
were incubated in a water bath (56℃) for 2 hr and then cen-
trifuged at 12,000 g for 10 min. The supernatant was col-
lected for assay of MPO activity as determined by measur-
ing the H2O2-dependent oxidation of o-DA (3,3′ -dimethoxy-
benzidine dihydrochloride) at 460 nm.
Assessment of lung edema
Evans blue dye (EBD) assay was performed to assess lung
leak using separate animals. EBD solution (5 mg/mL, 200
L) was injected through a tail vein (50 mg/kg). One hour
later, animals were anesthetized with inhaled isofluorane and
the chest was opened. The pulmonary vasculature was flush-
ed free of blood by gentle infusion of 10 mL of PBS into the
beating right ventricle. The lungs were then excised, weighed
and dried at 60℃for 24 hr, then placed in 3 mL of formamide
at 60℃ for 36 hr to extract EBD. Dye content was evaluat-
ed by spectrophotometry at 620 nm. 
Materials
Isoflurane was obtained from Abbott Laboratories (Chica-
go, IL, U.S.A.). RPMI 1640/25 mM HEPES/L-glutamine
was obtained from Bio-Whittaker Products (Walkersville,
MD, U.S.A.), and fetal bovine serum (FBS) and penicillin/
streptomycin were purchased from Gemini Bioproducts (Cal-
abasas, CA, U.S.A.). Custom cocktail antibodies and columns
for neutrophil isolation were purchased from Stem Cell Tech-
nologies (Vancouver, BC, Canada). All other reagents were
purchased from Sigma unless otherwise noted in the text. 
Isolation and culture of bone marrow-derived mouse
neutrophils
Bone marrow neutrophils were isolated according to the
manufacturer’s instructions. To obtain the bone marrow cell
suspension, the femur and tibia of a mouse were flushed with
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tion through a glass wool column, and cells were collected
by centrifugation. The cell pellets were resuspended in RPMI
1640, 1% fetal calf serum (FCS) and then incubated with
primary antibodies specific for cell surface markers F4/80,
CD4, CD45R, CD5, and TER119 for 15 min at 4℃. This
custom mixture is specific for T and B cells, RBC, mono-
cytes, and macrophages. After 15-min incubation, 100  L
of antibiotin tetrameric antibody complexes were added and
the cells were incubated for 15 min at 4℃. After this, 60  L
of colloidal magnetic dextran iron particles were added to
the suspension and incubated for 15 min at 4℃. The entire
cell suspension was then placed into a column surrounded
by a magnet. The T cells, B cells, RBC, monocytes, and
macrophages were captured in the column, allowing the neu-
trophils to pass through by negative-selection methods. Neu-
trophil purity, as determined by Wright’s stained cytospin
preparations, was greater than 97%. 
Stimulation of bone marrow-derived mouse neutrophils
with LPS and/or GM-CSF
Neutrophils were resuspended in RPMI 1640/10%-defin-
ed fetal calf serum at a final concentration of 5×105 cells/mL
and allocated into 1.5 mL microtube and stimulated with
LPS (1, 10, and 100 ng/mL) with or without GM-CSF (1, 10,
and 100 ng/mL) and suspended on the water bath (37℃)
for 4 hr. The supernatant was collected by centrifuging the
culture tube (12,000 g, 5 min) then stored at -70℃ before
being used for the measurement of cytokines. For the measure-
ment of mRNA expression, neutrophils (5×106 cells/tube)
were stimulated by LPS (100 ng/mL) with or without GM-
CSF (1, 10, and 100 ng/mL) on the water bath (37℃) for 1 hr.
Cytokine ELISA
Immunoreactive tumor necrosis factor- (TNF- ), macro-
phage inflammatory protein-2 (MIP-2), interleukin-1 (IL-
1 ), interleukin-6 (IL-6), and keratinocyte-derived chemokine
(KC) were quantitated using commercially available ELISA
kits (R&D Systems, Minneapolis, MN, U.S.A.), according to
the manufacturer’s instructions. 
Quantitative PCR
RNA was isolated using the RNAeasy kit (Qiagen, Valen-
cia, CA, U.S.A.) following the manufacturer’s protocol. Primers
and probes for TNF- were designed using Primer Express
software supplied by Applied Biosystems (Foster City, CA,
U.S.A.). The TNF- primer and probe consisted of the fol-
lowing: forward primer, 5′ -CTGTAGCCCACGTCGTAG-
TCAA-3′ ; reverse primer, 5′ -CTCCTGGTATGAGATAG-
CAAATCG-3′ ; probe, 6FAMTGCCCCGACTACGTGCT-
CCTCACMRA. The MIP-2 primer and probe consisted of
the following: forward primer, 5′ -TGTGACGCCCCCAG-
GA; reverse primer, 5′ -AACTTTTTGACCGCCCTTGAG-
3′ ; probe, 6FAMTGCGCCCAGACAGAAGTCATAGCC-
ATAMRA. The IL- 1 primer and probe consisted of the
following: forward primer, 5′ -GCTGAAAGCTCTCCAC-
CTCAA; reverse primer, 5′ -TCGTTGCTTGGTTCTCCT-
TGTA; probe, 6FAMCAGAATATCAACCAACAAGTG-
ATATTCTCCATGAGCTAMRA. All reagents used in the
one-step RT-PCR were purchased from Perkin Elmer (Fos-
ter City, CA, U.S.A.). Each one-step reverse trans criptase-
polymerase chain reaction (RT-PCR) contained a total vol-
ume of 50  L. The reverse transcription reaction was per-
formed for 30 min at 48℃ using MultiScribe Reverse Tran-
scriptase with a final concentration of 0.25 U/ L. After the
reverse transcription step, AmpliTaq Gold polymerase, with
a final concentration of 0.025 U/ L, was activated by an
increase in temperature to 95℃ for 10 min followed by 40
cycles of amplification (95℃ for 15 sec and 60℃ for 1 min)
with a Gene Amp 5700 Sequence Detection System (Applied
Biosystems, Foster City). Quantification was determined by
dividing the amount of GAPDH RNA by the target amount
for each cytokine RNA samples. 
Electrophoretic mobility shift assays
Nuclear extracts (20  g) were incubated at room temper-
ature for 15 min in 20  L of reaction buffer containing 10
mM Tris.HCl (pH 7.5), 1 mM MgCl2, 0.5 mM EDTA,
0.5 mM dithiothreitol, 10 mM 50 mM NaCl, and 4% glyc-
erol with 32P-end-labeled, double-stranded oligonucleotide
probe specific for the B site, 5′ -GCCATGGGGGGATCC-
CCGAAGTCC-3′(Active Motive, Carlsbad, CA, U.S.A.)
and 1  g of poly (dI-dC).poly(dI-dC). The complexes were
resolved on 5% polyacrylamide gels in Tris .HCl (pH 8.0)-
borate-EDTA buffer at 10 V/cm. Dried gels were exposed
with Kodak Biomax MS film (Rochester, NY, U.S.A.) for 1-
24 hr at -70℃.
Statistical analysis
To limit variability and to provide appropriate controls
for each experimental condition, the entire group of animals
was prepared and studied at the same time. More than 5 mice
were used in each group for lung cytokines, MPO, and EBD
assays. One way analysis of variance (ANOVA) and Tukey-
Kramer multiple comparisons test were used for analysis of
multiple groups.
RESULTS
GM-CSF -/- mice were more resistant to lung injury induced
by LPS injection or hemorrhage than the C57BL mice
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peritoneal LPS injection, GM-CSF -/- mice showed less of
an increase in MPO activity than did the C57BL control mice
(p<0.05) (Fig. 1A). GM-CSF -/- mice were resistant to lung
leakage even with high doses of LPS injection (Fig. 2A). GM-
CSF -/- mice did not show an increase in MPO activity or lung
leakage after hemorrhage (Fig. 1B, 2B). 
GM-CSF -/- mice expressed lower levels of cytokines in
the lung after LPS injection or hemorrhage than did the
C57BL mice 
The expression of lung TNF- did not increase even with
high doses of the LPS injection (5 mg/kg) in the GM-CSF -/-
mice (Fig. 3). The expression of MIP-2 and IL-1 in the lung
increased with low (0.5 mg/kg) or high (5 mg/kg) doses of
LPS injection in the GM-CSF -/- mice. However, it was much
lower in the GM -/- mice than in the C57BL mice (Fig. 3).
The expression of lung TNF- and MIP-2 did not increase
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Fig. 1. GM-CSF -/- mice showed decreased infiltration of neutrophils
in the lung after LPS injection or hemorrhage. GM-CSF -/- mice
and control C57BL mice were treated with low or high doses of
LPS (0.5 mg/kg or 5 mg/kg, respectively) injected into the peri-
toneum. Four hours after the injection of LPS or hemorrhage, mice
were sacrificed and lung neutrophil infiltration was evaluated by
MPO assay. Each group consisted of five mice.
GM-/-, GM-CSF knockout mice; C57, C57BL control mice; Hmr,
hemorrhage; LPS 0.5, LPS 0.5 mg/kg i.p.; LPS 5, LPS 5 mg/kg
i.p. *, p<0.05.
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Fig. 2. GM-CSF-/- mice were resistant to lung leakage after LPS
injection or hemorrhage. GM-CSF -/- mice or control C57BL mice
were treated with low or high doses of LPS (0.5 mg/kg and 5 mg/kg,
respectively) injected into the peritoneum. Three hours after the
injection of LPS or hemorrhage, Evans blue dye (50 mg/kg) was
injected into the tail vein. One hour after the injection of dye, mice
were sacrificed and the lungs were removed. EBD was extract-
ed from the removed lungs by formamide extraction. Each group
consisted of five mice.
GM-/-, GM-CSF knockout mice; C57, C57BL control mice; Hmr,
hemorrhage; LPS 0.5, LPS 0.5 mg/kg i.p.; LPS 5, LPS 5 mg/kg i.p.
*, p<0.05.
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Fig. 3. GM-CSF -/- mice showed decreased levels of TNF- , MIP-
2, and IL-1 in the lung after LPS injection. GM-CSF -/- mice and
control C57BL mice were treated with low or high doses of LPS
(0.5 mg/kg or 5 mg/kg, respectively) injected into the peritoneum.
Four hours after the injection of LPS, mice were sacrificed, and
expression of TNF- , MIP-2 and IL-1 in the lung samples were
evaluated by ELISA. Each group consisted of five mice. *, p<0.05.
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in the hemorrhage model. Therefore, we evaluated two other
cytokines, KC and IL-6. In the control state, there was no
significant difference in the expression of the three cytokines
(KC, IL-6, and IL-1 ) between the GM-CSF -/- and the C57BL
mice. However, after hemorrhage, the expression of the three
cytokines in the lung was higher in the C57BL mice than
in the GM-CSF -/- mice (Fig. 4).
GM-CSF augments the expression of TNF- , MIP-2, and
IL-1 in neutrophils 
GM-CSF showed a limited stimulatory effect on the expres-
sion of TNF- and MIP-2 of polymorphonuclear leukocyte
(PMN) when it was administered alone or with low or medi-
um doses of LPS (LPS 1 and 10 ng/mL) (Fig. 5A, B). When
incremental doses of GM-CSF (0, 1, 10, or 100 ng/mL) were
added to high doses of LPS (100 ng/mL), the expression of
TNF- (mean±SEM) (468±59, 673±140, 1,264±210,
and 1,916±599 pg/mL, respectively) (p<0.05) (Fig. 5A)
and MIP-2 (313±64, 325±30, 569±112, and 468±74
pg/mL, respectively) (p<0.05) (Fig. 5B) of PMN increased in
a dose-dependent manner. GM-CSF augmented LPS induced
IL-1 expression of PMN at all three doses of administered
LPS (Fig. 5C).
GM-CSF augments the mRNA expression of TNF- , MIP-
2, and IL-1 of PMN mediated by increased intranuclear
translocation of NF- B
The mRNA expression of TNF- , MIP-2, and IL-1 was
higher when incremental doses of GM-CSF (1, 10, and 100
ng/mL) were added with LPS (100 ng/mL) than when LPS
was used for treatment alone (p<0.05) (Fig. 6). This apparent
synergistic effect of GM-CSF on LPS induced mRNA expres-
sion of three cytokines of PMN was mediated by increased
intranuclear translocation of NF- B (Fig. 7). 
DISCUSSION
The immuno-stimulatory effects of GM-CSF have been
utilized in clinical practice to stimulate the production of
granulocytes and macrophages in neutropenic, febrile patients.
In addition, because low-dose GM-CSF has been shown to
be associated with improved pulmonary gas exchange, with-
out neutrophil infiltration (12), there have been clinical tri-
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Fig. 4. GM-CSF -/- mice showed decreased levels of KC, IL-6, and
IL-1 in the lung after hemorrhage. Four hours after hemorrhage,
mice were sacrificed and the expression of KC, IL-6, and IL-1 in
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als that have evaluated GM-CSF as supportive therapy for
systemic inflammatory diseases. For example, one study show-
ed that the addition of GM-CSF to antibiotic therapy reduced
the rate of infectious complications, the length of hospital-
ization, as well as costs, in patients with nontraumatic ab-
dominal sepsis (13).
However, GM-CSF-induced hyper-stimulation of inflam-
matory cells has resulted in abnormal physiologic side effects
as well. Hypothermia and loss of body weight were marked-
ly attenuated in LPS-treated GM-CSF-deficient mice com-
pared to similarly treated control mice (8). Moreover, the
levels of circulating IFN- , IL-1 , and IL-6 were lower in
LPS-treated GM-CSF-deficient mice than LPS-treated con-
trol mice (14). These observations suggest that GM-CSF
augments the cytokine production related to LPS-mediated
septic shock, and may aggravate systemic inflammation and
tissue injury. 
Taking into consideration of mutually contradicting find-
ings, we hypothesized that the physiologic effects of GM-
CSF on inflammation are dependent on the levels of LPS it
encounters. We treated low (0.5 mg/kg) or high (5 mg/kg)
doses of LPS into peritoneum of Balb/c mice to induce endo-
toxemia and ALI, the doses of which were in accordance with
the previous study (15). Our hypothesis was supported by
the in vivo study. In LPS-induced lung injury, the GM-CSF
-/- mice showed less infiltration of neutrophils in the lung
(in MPO assay, Fig. 1A) and more resistance to lung leakage
(in EBD assay, Fig. 2A) than did the control C57BL mice.
This apparent protective effect of the GM-CSF knockout state
was more prominent when the dose of injected LPS was high
(5 mg/kg). In addition, the expression of MIP-2 or IL-1 in
the lung was lower in the GM-CSF -/- mice both at low (0.5
mg/kg) and high doses (5 mg/kg) of LPS injection (Fig. 3).
Of note was that the TNF- expression, which was not dif-
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Fig. 6. GM-CSF augments LPS-induced mRNA expression of
TNF- , MIP-2, and IL-1 in mouse bone marrow neutrophils. LPS
(100 ng/mL) and incremental concentration of GM-CSF (0, 1, 10,
and 100 ng/mL) was added to bone marrow neutrophils of con-
trol mice (1×10
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centrifuged for 12,000 g at 4 ° C and total RNA was collected. The
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Fig. 7. GM-CSF augments LPS-induced nuclear translocation of
NF- B in mouse bone marrow neutrophils. Isolated neutrophils
were allocated into 1.5 mL microtubes (10
7 cells/tube). LPS (100
ng/mL) and incremental concentrations of GM-CSF (0, 1, 10, and
100 ng/mL) were added to bone marrow neutrophils of control
mice. One hour later, the microtube was centrifuged at 12,000 g
and 4 ° C and the nuclear protein was extracted for EMSA. The
upper figure and lower graph are representatives of three inde-
pendent experiments. GM, GM-CSF.
*
M
I
P
-
2
/
G
A
P
D
H
 
r
a
t
i
o
18
16
14
12
10
8
6
4
2
0
Control LPS100 LPS100/ LPS100/ LPS100/
GM1 GM10 GM100
*
I
L
-
1
b
/
G
A
P
D
H
 
r
a
t
i
o
16
14
12
10
8
6
4
2
0
Control LPS100 LPS100/ LPS100/ LPS100/
GM1 GM10 GM100
*
D
e
n
s
i
t
y
8
7
6
5
4
3
2
1
0
Control LPS100 LPS100/ LPS100/ LPS100/
GM1 GM10 GM100
1: Control
2: LPS 100 ng/mL
3: LPS 100/GM 1 ng/mL
4: LPS 100/GM 10 ng/mL
5: LPS 100/GM 100 ng/mL
1234 5294 J.C. Choi, J.W. Jung, H.W. Kwak, et al.
ferent between the two groups of mice at low doses of LPS
injection, increased only in the C57BL mice with high doses
of LPS injection. In the hemorrhage model, the GM-CSF -/-
mice were more resistant to neutrophil infiltration (Fig. 1B)
and lung leakage (Fig. 2B) than the C57BL mice after hem-
orrhage. In addition, the GM-CSF -/- mice showed a lower
level of inflammatory cytokine (KC, IL-6, and IL-1 ) expres-
sion compared to the control C57BL mice (Fig. 4). These
findings imply that GM-CSF plays an important role not
only in LPS-induced but also in hemorrhage-induced acute
lung injury. This is the first report to implicate GM-CSF in
acute hemorrhage-induced lung injury. Although our data
seem to support the harmful effect of GM-CSF in systemic
inflammation, the positive side of bioactivity of GM-CSF
should be considered as well. For example, GM-CSF knock-
out mice improved bacterial clearance after expression of GM-
CSF in the respiratory epithelium (16). In this sense, our
data need to be accepted as one of those that emphasize the
role of GM-CSF as an augmenting agent of inflammation.
In the in vitro study, co-treatment of GM-CSF with low or
medium doses of LPS (1 and 10 ng/mL, respectively) showed
no stimulatory effects on the expression of TNF- and MIP-
2 in bone marrow neutrophils. However, the expression of
IL-1 , which appears to play an important role in ALI, increas-
ed in a dose dependent manner with addition of low or medi-
um (10 ng/mL) doses of GM-CSF. Of note, when GM-CSF
was administered with high doses of LPS (100 ng/mL), the
expression of three cytokines (TNF- , MIP-2, or IL-1 )
increased; this was dependent on the dose of GM-CSF used
(Fig. 5). The incubation time from the administration of
GM-CSF and/or LPS to collection of supernatant was only 1
hr. Therefore, GM-CSF might augment the expression of
proinflammatory cytokines by its priming effects on neu-
trophils rather than by delaying apoptosis of neutrophils. In
the RT-PCR assay, the combination of GM-CSF with high
doses of LPS increased the expression of mRNA of three
cytokines (TNF- , MIP-2, and IL-1 ; Fig. 6). These results
imply that GM-CSF-induced augmentation of inflammato-
ry cytokine production is regulated at the transcriptional
level. In addition, intranuclear translocation of NF- B was
increased in a dose dependent fashion with incremental doses
of GM-CSF (Fig. 7). It is well known that NF- B plays an
important role in the mediation of LPS-induced stimulation
of proinflammatory cytokines (17). The augmentation of
GM-CSF with LPS appears to be mediated by the same mech-
anism involved in LPS-induced inflammation. The above
findings suggest that GM-CSF augments lung inflamma-
tion not only by increasing recruitment of neutrophils into
lung tissue but also by its priming effects on neutrophils.
GM-CSF especially augmented high doses of LPS-induced
inflammation, which was consistent, with the in vivo study
results.
In summary, GM-CSF knockout mice were more resistant
to lung inflammation and lung injury than C57BL control
mice, which were induced by LPS-injection or hemorrhage.
GM-CSF augmented the inflammatory effect of high dose
LPS, which appears to be regulated at the transcriptional level
and mediated by NF- B translocation. In conclusion, GM-
CSF plays an important role in not only LPS-induced but
also hemorrhage-induced ALI by its priming effects on neu-
trophils.
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